001     182352
005     20240229145717.0
024 7 _ |a 10.1161/CIRCULATIONAHA.122.060700
|2 doi
024 7 _ |a 0009-7322
|2 ISSN
024 7 _ |a 0065-8499
|2 ISSN
024 7 _ |a 1524-4539
|2 ISSN
024 7 _ |a altmetric:137887676
|2 altmetric
024 7 _ |a pmid:36314129
|2 pmid
037 _ _ |a DKFZ-2022-02595
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Gaziano, Liam
|b 0
245 _ _ |a Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
260 _ _ |a [S.l.]
|c 2022
|b Ovid
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1668783574_29164
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Nov 15;146(20):1507-1517
520 _ _ |a Background: End-stage renal disease is associated with a high risk of cardiovascular events. It is unknown, however, whether mild-to-moderate kidney dysfunction is causally related to coronary heart disease (CHD) and stroke.Methods: Observational analyses were conducted using individual-level data from 4 population data sources (Emerging Risk Factors Collaboration, EPIC-CVD [European Prospective Investigation into Cancer and Nutrition-Cardiovascular Disease Study], Million Veteran Program, and UK Biobank), comprising 648 135 participants with no history of cardiovascular disease or diabetes at baseline, yielding 42 858 and 15 693 incident CHD and stroke events, respectively, during 6.8 million person-years of follow-up. Using a genetic risk score of 218 variants for estimated glomerular filtration rate (eGFR), we conducted Mendelian randomization analyses involving 413 718 participants (25 917 CHD and 8622 strokes) in EPIC-CVD, Million Veteran Program, and UK Biobank.Results: There were U-shaped observational associations of creatinine-based eGFR with CHD and stroke, with higher risk in participants with eGFR values <60 or >105 mL·min-1·1.73 m-2, compared with those with eGFR between 60 and 105 mL·min-1·1.73 m-2. Mendelian randomization analyses for CHD showed an association among participants with eGFR <60 mL·min-1·1.73 m-2, with a 14% (95% CI, 3%-27%) higher CHD risk per 5 mL·min-1·1.73 m-2 lower genetically predicted eGFR, but not for those with eGFR >105 mL·min-1·1.73 m-2. Results were not materially different after adjustment for factors associated with the eGFR genetic risk score, such as lipoprotein(a), triglycerides, hemoglobin A1c, and blood pressure. Mendelian randomization results for stroke were nonsignificant but broadly similar to those for CHD.Conclusions: In people without manifest cardiovascular disease or diabetes, mild-to-moderate kidney dysfunction is causally related to risk of CHD, highlighting the potential value of preventive approaches that preserve and modulate kidney function.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Sun, Luanluan
|b 1
700 1 _ |a Arnold, Matthew
|b 2
700 1 _ |a Bell, Steven
|0 0000-0001-6774-3149
|b 3
700 1 _ |a Cho, Kelly
|b 4
700 1 _ |a Kaptoge, Stephen K.
|b 5
700 1 _ |a Song, Rebecca J.
|b 6
700 1 _ |a Burgess, Stephen
|b 7
700 1 _ |a Posner, Daniel C.
|0 0000-0002-3056-6924
|b 8
700 1 _ |a Mosconi, Katja
|b 9
700 1 _ |a Robinson-Cohen, Cassianne
|b 10
700 1 _ |a Mason, Amy
|0 0000-0002-8019-0777
|b 11
700 1 _ |a Bolton, Thomas R.
|b 12
700 1 _ |a Tao, Ran
|b 13
700 1 _ |a Allara, Elias
|0 0000-0002-1634-8330
|b 14
700 1 _ |a Schubert, Petra
|b 15
700 1 _ |a Chen, Lingyan
|b 16
700 1 _ |a Staley, James R.
|b 17
700 1 _ |a Staplin, Natalie
|0 0000-0003-4482-4418
|b 18
700 1 _ |a Altay, Servet
|b 19
700 1 _ |a Amiano, Pilar
|b 20
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 21
|u dkfz
700 1 _ |a Ärnlöv, Johan
|0 0000-0002-6933-4637
|b 22
700 1 _ |a Barr, Elizabeth L. M.
|0 0000-0003-4284-1716
|b 23
700 1 _ |a Björkelund, Cecilia
|b 24
700 1 _ |a Boer, Jolanda M. A.
|0 0000-0002-9714-4304
|b 25
700 1 _ |a Brenner, Hermann
|b 26
700 1 _ |a Casiglia, Edoardo
|0 0000-0002-0003-3289
|b 27
700 1 _ |a Chiodini, Paolo
|0 0000-0003-0139-2264
|b 28
700 1 _ |a Cooper, Jackie A.
|b 29
700 1 _ |a Coresh, Josef
|0 0000-0002-4598-0669
|b 30
700 1 _ |a Cushman, Mary
|0 0000-0002-7871-6143
|b 31
700 1 _ |a Dankner, Rachel
|b 32
700 1 _ |a Davidson, Karina W.
|0 0000-0002-9162-477X
|b 33
700 1 _ |a de Jongh, Renate T.
|0 0000-0001-8414-3938
|b 34
700 1 _ |a Donfrancesco, Chiara
|b 35
700 1 _ |a Engström, Gunnar
|0 0000-0002-8618-9152
|b 36
700 1 _ |a Freisling, Heinz
|b 37
700 1 _ |a de la Cámara, Agustin Gómez
|0 0000-0001-6827-6319
|b 38
700 1 _ |a Gudnason, Vilmundur
|0 0000-0001-5696-0084
|b 39
700 1 _ |a Hankey, Graeme J.
|0 0000-0002-6044-7328
|b 40
700 1 _ |a Hansson, Per-Olof
|0 0000-0001-6323-0506
|b 41
700 1 _ |a Heath, Alicia K.
|0 0000-0001-6517-1300
|b 42
700 1 _ |a Hoorn, Ewout J.
|0 0000-0002-8738-3571
|b 43
700 1 _ |a Imano, Hironori
|0 0000-0002-6661-4254
|b 44
700 1 _ |a Jassal, Simerjot K.
|0 P:(DE-HGF)0
|b 45
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 46
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 47
|u dkfz
700 1 _ |a Kauhanen, Jussi
|b 48
700 1 _ |a Kiechl, Stefan
|0 0000-0002-9836-2514
|b 49
700 1 _ |a Koenig, Wolfgang
|0 0000-0002-2064-9603
|b 50
700 1 _ |a Kronmal, Richard A.
|0 0000-0002-9897-7076
|b 51
700 1 _ |a Kyrø, Cecilie
|0 0000-0002-9083-8960
|b 52
700 1 _ |a Lawlor, Deborah A.
|b 53
700 1 _ |a Ljungberg, Börje
|0 0000-0002-4121-3753
|b 54
700 1 _ |a MacDonald, Conor
|0 0000-0002-4989-803X
|b 55
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 56
700 1 _ |a Meisinger, Christa
|b 57
700 1 _ |a Melander, Olle
|b 58
700 1 _ |a Moreno Iribas, Conchi
|b 59
700 1 _ |a Ninomiya, Toshiharu
|0 0000-0003-1345-9032
|b 60
700 1 _ |a Nitsch, Dorothea
|b 61
700 1 _ |a Nordestgaard, Børge G.
|0 0000-0002-1954-7220
|b 62
700 1 _ |a Onland-Moret, Charlotte
|0 0000-0002-2360-913X
|b 63
700 1 _ |a Palmieri, Luigi
|0 0000-0002-4298-2642
|b 64
700 1 _ |a Petrova, Dafina
|b 65
700 1 _ |a Garcia, Jose Ramón Quirós
|b 66
700 1 _ |a Rosengren, Annika
|0 0000-0002-5409-6605
|b 67
700 1 _ |a Sacerdote, Carlotta
|b 68
700 1 _ |a Sakurai, Masaru
|b 69
700 1 _ |a Santiuste, Carmen
|b 70
700 1 _ |a Schulze, Matthias B.
|0 0000-0002-0830-5277
|b 71
700 1 _ |a Sieri, Sabina
|0 0000-0001-5201-172X
|b 72
700 1 _ |a Sundström, Johan
|0 0000-0003-2247-8454
|b 73
700 1 _ |a Tikhonoff, Valérie
|0 0000-0001-7846-0101
|b 74
700 1 _ |a Tjønneland, Anne
|b 75
700 1 _ |a Tong, Tammy
|0 0000-0002-0284-8959
|b 76
700 1 _ |a Tumino, Rosario
|b 77
700 1 _ |a Tzoulaki, Ioanna
|0 0000-0002-4275-9328
|b 78
700 1 _ |a van der Schouw, Yvonne T.
|0 0000-0002-4605-435X
|b 79
700 1 _ |a Monique Verschuren, W. M.
|b 80
700 1 _ |a Völzke, Henry
|b 81
700 1 _ |a Wallace, Robert B.
|b 82
700 1 _ |a Goya Wannamethee, S.
|0 0000-0001-9484-9977
|b 83
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 84
700 1 _ |a Willeit, Peter
|0 0000-0002-1866-7159
|b 85
700 1 _ |a Woodward, Mark
|0 0000-0001-9800-5296
|b 86
700 1 _ |a Yamagishi, Kazumasa
|0 0000-0003-3301-5519
|b 87
700 1 _ |a Zamora-Ros, Raul
|0 0000-0002-6236-6804
|b 88
700 1 _ |a Akwo, Elvis A.
|b 89
700 1 _ |a Pyarajan, Saiju
|b 90
700 1 _ |a Gagnon, David R.
|0 0000-0002-6367-3179
|b 91
700 1 _ |a Tsao, Philip S.
|0 0000-0001-7274-9318
|b 92
700 1 _ |a Muralidhar, Sumitra
|b 93
700 1 _ |a Edwards, Todd L.
|0 0000-0003-4318-6119
|b 94
700 1 _ |a Damrauer, Scott M.
|0 0000-0001-8009-1632
|b 95
700 1 _ |a Joseph, Jacob
|0 0000-0002-7279-4896
|b 96
700 1 _ |a Pennells, Lisa
|0 0000-0002-8594-3061
|b 97
700 1 _ |a Wilson, Peter W. F.
|b 98
700 1 _ |a Harrison, Seamus
|b 99
700 1 _ |a Gaziano, Thomas A.
|0 0000-0002-5985-345X
|b 100
700 1 _ |a Inouye, Michael
|b 101
700 1 _ |a Baigent, Colin
|b 102
700 1 _ |a Casas, Juan P.
|b 103
700 1 _ |a Langenberg, Claudia
|0 0000-0002-5017-7344
|b 104
700 1 _ |a Wareham, Nick
|0 0000-0003-1422-2993
|b 105
700 1 _ |a Riboli, Elio
|b 106
700 1 _ |a Michael Gaziano, J.
|b 107
700 1 _ |a Danesh, John
|b 108
700 1 _ |a Hung, Adriana M.
|0 0000-0002-3203-1608
|b 109
700 1 _ |a Butterworth, Adam S.
|0 0000-0002-6915-9015
|b 110
700 1 _ |a Wood, Angela M.
|b 111
700 1 _ |a Di Angelantonio, Emanuele
|0 0000-0001-8776-6719
|b 112
700 1 _ |a Koettgen, Anna
|b 113
700 1 _ |a Shaw, Jonathan
|b 114
700 1 _ |a Atkins, Robert
|b 115
700 1 _ |a Zimmet, Paul
|b 116
700 1 _ |a Whincup, Peter
|b 117
700 1 _ |a Willeit, Johann
|b 118
700 1 _ |a Leitner, Christoph
|b 119
700 1 _ |a Schnohr, Peter
|b 120
700 1 _ |a Afzal, Shoaib
|b 121
700 1 _ |a Pablos, David Lora
|b 122
700 1 _ |a Arriscado, Cristina Martin
|b 123
700 1 _ |a Ferreiro, Carmen Romero
|b 124
700 1 _ |a Stocker, Hannah
|b 125
700 1 _ |a Schöttker, Ben
|b 126
700 1 _ |a Holleczek, Bernd
|b 127
700 1 _ |a Chetrit, Angela
|b 128
700 1 _ |a Welin, Lennart
|b 129
700 1 _ |a Svärdsudd, Kurt
|b 130
700 1 _ |a Welin, Lennart
|b 131
700 1 _ |a Svärdsudd, Kurt
|b 132
700 1 _ |a Lissner, Lauren
|b 133
700 1 _ |a Hange, Dominique
|b 134
700 1 _ |a Mehlig, Kirsten
|b 135
700 1 _ |a Nagel, Dorothea
|b 136
700 1 _ |a Norman, Paul E.
|b 137
700 1 _ |a Almeida, Osvaldo
|b 138
700 1 _ |a Flicker, Leon
|b 139
700 1 _ |a Hata, Jun
|b 140
700 1 _ |a Honda, Takanori
|b 141
700 1 _ |a Furuta, Yoshihiko
|b 142
700 1 _ |a Iso, Hiroyasu
|b 143
700 1 _ |a Kitamura, Akihiko
|b 144
700 1 _ |a Muraki, Isao
|b 145
700 1 _ |a Salonen, Jukka T.
|b 146
700 1 _ |a Tuomainen, Tomi-Pekka
|b 147
700 1 _ |a van Zutphen, E. M.
|b 148
700 1 _ |a van Schoor, N. M.
|b 149
700 1 _ |a Lo Noce, Cinzia
|b 150
700 1 _ |a Lappas, Georg
|b 151
700 1 _ |a Nilsson, Peter M.
|b 152
700 1 _ |a Hedblad, Bo
|b 153
700 1 _ |a Shaffer, Jonathan
|b 154
700 1 _ |a Schwartz, Joseph
|b 155
700 1 _ |a Shimbo, Daichi
|b 156
700 1 _ |a Sato, Shinichi
|b 157
700 1 _ |a Iso, Hiroyasu
|b 158
700 1 _ |a Hayama-Terada, Mina
|b 159
700 1 _ |a Aspelund, Thor
|b 160
700 1 _ |a Thorsson, Bolli
|b 161
700 1 _ |a Sigurdsson, Gunnar
|b 162
700 1 _ |a Chaker, Layal
|b 163
700 1 _ |a Ikram, Kamran M.
|b 164
700 1 _ |a Kavousi, Maryam
|b 165
700 1 _ |a Tunstall-Pedoe, Hugh
|b 166
700 1 _ |a Can, Günay
|b 167
700 1 _ |a Yüksel, Hüsniye
|b 168
700 1 _ |a Özkan, Uğur
|b 169
700 1 _ |a Nakagawa, Hideaki
|b 170
700 1 _ |a Morikawa, Yuko
|b 171
700 1 _ |a Ishizaki, Masao
|b 172
700 1 _ |a Feskens, Edith
|b 173
700 1 _ |a Geleijnse, Johanna M
|b 174
700 1 _ |a Kromhout, Daan
|b 175
773 _ _ |a 10.1161/CIRCULATIONAHA.122.060700
|g p. CIRCULATIONAHA.122.060700
|0 PERI:(DE-600)1466401-X
|n 20
|p 1507-1517
|t Circulation
|v 146
|y 2022
|x 0009-7322
909 C O |p VDB
|o oai:inrepo02.dkfz.de:182352
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 45
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 46
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 47
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-29
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2022-11-19
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CIRCULATION : 2021
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-19
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b CIRCULATION : 2021
|d 2022-11-19
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21